Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital of North Norway
About this trial
The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.
Eligibility criteria
Qualifiers
Alzheimer's dementia mild to moderate stage
Presence of Alzheimer pathology core 1 biomarkers as defined by National Institute on Aging-Alzheimer's Association (NIA-AA) criteria (2024)
Capable of giving informed consent
Disqualifiers
Contraindications for colonoscopy examination
Contraindications for Magnetic Resonance Imaging (MRI)
Life expectancy < 1 year
Clinical frailty scale 7 or more
Trial design
Treatments tested in this trial
- Biological: Preprocessed thawed donor FMT
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
University Hospital of North Norway
Lead sponsor
UiT The Arctic University of Norway
Collaborator
Source ClinicalTrials.gov